The Combination of the CDK4/6 Inhibitor, Palbociclib, With the Vitamin D3 Analog, Inecalcitol, Has Potent In Vitro and In Vivo Anticancer Effects in Hormone-Sensitive Breast Cancer, But Has a More Limited Effect in Triple-Negative Breast Cancer

CDK4/6 抑制剂 Palbociclib 与维生素 D3 类似物 Inecalcitol 的组合对激素敏感性乳腺癌具有强大的体外和体内抗癌作用，但对三阴性乳腺癌的作用较有限